Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2003
10/02/2003US20030186368 Comprise nucleotide sequences coding membrane protein for use as antitumor, antiproliferative, anticarcinogenic or antiinflammatory agents
10/02/2003US20030186367 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030186366 For stimulating release of tumor necrosis factor and/or cellular differentiation of chondrocytes, endothelial cells or adipocytes by contacting blood with pro-polypeptide; cancer diagnosis and treatment
10/02/2003US20030186365 Comprise nucleotide sequences coding membrane protein for use as antitumor, antiproliferative, anticarcinogenic or antiinflammatory agents
10/02/2003US20030186364 For producing vaccines for the prevention or attenuation of infection by Staphylococcus
10/02/2003US20030186362 Comprises nucleotide sequences coding chimeric/fusion protein for generation disease resistant plants; antiproliferative/anticarcinogenic agents
10/02/2003US20030186361 Comprise nucleotide sequences coding membrane protein for use as antitumor, antiproliferative, anticarcinogenic or antiinflammatory agents
10/02/2003US20030186360 Comprises nucleotide sequences coding membrane protein for use in diagnosis and treatment of disorders of colon, urogenital and autoimmune systems
10/02/2003US20030186359 Genes encoding insect odorant receptors and uses thereof
10/02/2003US20030186358 Comprise nucleotide sequences coding membrane protein for use as antitumor, antiproliferative, anticarcinogenic or antiinflammatory agents
10/02/2003US20030186357 Vertebrate embryonic pattern-inducing proteins, and uses related thereto
10/02/2003US20030186356 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
10/02/2003US20030186342 Immunoenzymatic quantification method
10/02/2003US20030186340 Amino acid sequences for use as diagnostic markers in bioassays; immunohistochemistry
10/02/2003US20030186337 Novel death associated proteins, and THAP1 and PAR4 pathways in apoptosis control
10/02/2003US20030186334 KTS-disintegrins
10/02/2003US20030186333 Comprises nervous system polypeptide for diagnosis, prognosis, treatment and evaluation of neurodegenerative disorders
10/02/2003US20030186332 CompriseS nucleotide sequences coding neurotrophic factor expression-inducing agent (PSEC56 protein) for designing therapies for treating nervous system disorders
10/02/2003US20030186325 Method of screening for inhibitors of osteopontin
10/02/2003US20030186324 Sensory neuron receptors
10/02/2003US20030186323 Force-regulated molecular recognition switches
10/02/2003US20030186321 Comprises polypeptide having antitumor, immunomodulatory and viricidal activity for treating leukemia, hepatitis and autoimmune diseases
10/02/2003US20030186319 Comprises nucleotide sequences coding membrane protein for use as antiinflammatory/antitumor/anticarcinogenic/ antiproliferative agents
10/02/2003US20030186318 Comprises nucleotide sequences coding membrane protein for use as antiinflammatory/antitumor/anticarcinogenic/ antiproliferative agents
10/02/2003US20030186317 Identifying modulators of calcium-binding protein (CIB)/mixed lineage kinase 2 (MLK2) complexes for treatment and prevention of nervous system disorders
10/02/2003US20030186316 Method for identifying optimal binding ligands to a receptor
10/02/2003US20030186309 Bioassay for detecting genetic mutation and phenotyping tumor suppression and/or gene regulation in mammalian cells
10/02/2003US20030186308 Prostacyclin-stimulating factor-2
10/02/2003US20030186306 Nucleotide sequences coding interleukins for treating tumors, bone, nervous system, neovascularization and autoimmune disorders
10/02/2003US20030186304 Comprises protein for diagnosis and treatment of cardiovascular disorders
10/02/2003US20030186297 Comprises nucleotide sequences coding osteoclast polypeptides (OCL) for diagnosing and treating osteoporosis, bone disorders, cancer, hypercalcemia and arthritis
10/02/2003US20030186294 Method of diagnosing and treating lesion of crystalline lens using human crygs gene and coding product thereof
10/02/2003US20030186290 Gene involved in CADASIL, method of diagnosis and therapeutic application
10/02/2003US20030186286 Suppressor of cytokine signaling (SOCS)-3 promoter and methods for its use in genetic therapy in humans
10/02/2003US20030186283 Azodicarbonamide ejects zinc bound to protein; solid phase synthesis; nuclear magnetic resonance
10/02/2003US20030186281 Modified tetracycline repressor protein compositions and methods of use
10/02/2003US20030186277 Nucleic acids for diagnosis of cancer, rheumatic diseases, arthritic, skin and blood disorders 0
10/02/2003US20030186275 Using bacterial peptides to develop vaccine to protect against mycobacterium infections
10/02/2003US20030186273 Using transport protein to treat cardiovascular and neovascularization disorders
10/02/2003US20030186269 Ssa-56 kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
10/02/2003US20030186267 Novel human leucine-rich repeat domain containing protein, HLLRCR-1
10/02/2003US20030186265 Novel human G-protein coupled receptor, HGPRBMY7, expressed highly in spinal cord
10/02/2003US20030186254 Comprises nucleotide sequences coding serine/threonine kinase (PAK4) which effects guanyl-nucleotide exchange factor (GEF) activity for diagnosis and treatment of viral diseases
10/02/2003US20030186253 Fibroblast growth factor-13
10/02/2003US20030186249 Comprises nucleotide sequences coding a thymocyte cyclic AMP regulated phosphoprotein (TARPP) for treating, diagnosing, monitoring, prognosticating or preventing nervous system disorders
10/02/2003US20030186242 Comprise enzymatic polypepdide for diagnosis, prevention and treatment of tumors; antiproliferative agents
10/02/2003US20030186241 Comprises enzymatic polypeptide for diagnosis, prevention and treatment of cancers; antiproliferative agents
10/02/2003US20030186236 Diagnosis and prevention of infectibity of swine with porcine reproductive and respiratory syndrome virus; viricides; animal husbandry
10/02/2003US20030186235 For use in research, diagnosis, drug discovery, therapy, clinical medicine, forensic science
10/02/2003US20030186232 Human and non-human primate homologues of Nkd protein, nucleic acid sequences encoding, and uses thereof
10/02/2003US20030186231 Systematic evolution of ligands by exponential enrichment: Chemi-ESLEX
10/02/2003US20030186229 Emission ratiometric indicators of phosphorylation
10/02/2003US20030186225 Comprises DNA sequences coding viral protein for use in developing vaccine which prevents porcine reproductive and respiratory syndrome viral infections
10/02/2003US20030186224 CD4+ T-lymphocyte-specific hepatitis C virus-epitopes
10/02/2003US20030186219 Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits
10/02/2003US20030186215 Using signal transducers and activator of transcription inhibitory factor-1 (STATIF-1) for prevention and treatment of diabetes
10/02/2003US20030185898 Cartilage-Derived morphogenetic proteins
10/02/2003US20030185890 Compositions and methods for polynucleotide delivery
10/02/2003US20030185862 Fusion peptide of human type- I collagen derived peptide and Tat peptide, preparation therof, and skin anti-aging cosmetic composition comprising the same
10/02/2003US20030185859 Lyme disease vaccine
10/02/2003US20030185858 Engineered for both enhanced stability of self-assembled particles and the display of an immunogenic epitope.
10/02/2003US20030185857 Recombinant urine derived protein capable of binding to a purified HBV derived polypeptide
10/02/2003US20030185854 Use of recombinant hepatitis B core particles to develop vaccines against infectious pathogens and malignancies
10/02/2003US20030185852 Parasitic protozoan isolate
10/02/2003US20030185850 Protective peptides neurotoxin of C. botulinum
10/02/2003US20030185849 React with convalescent phase antiserum from an E. canis-infected dog; useful in the development of vaccines and serodiagnostics
10/02/2003US20030185848 Using such isolated antigens for producing immune responses in bovines or other non-human animals.
10/02/2003US20030185846 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030185845 Such as variants of interleukin 5 and tumour necrosis factor alpha
10/02/2003US20030185844 Isolated nucleic acid molecules encoding isolated peptides which correspond to contiguous amino acids of an SSX molecule or NY-ESO-1 and uses thereof
10/02/2003US20030185843 Heat shock protein-based vaccines and immunotherapies
10/02/2003US20030185842 Heat shock protein-based vaccines and immunotherapies
10/02/2003US20030185841 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030185840 Induction of tumor immunity by variants of folate binding protein
10/02/2003US20030185837 Serodiagnostic assays
10/02/2003US20030185836 Cryptosporidium sporozoite antigens
10/02/2003US20030185833 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
10/02/2003US20030185830 Compositions and methods for the therapy and diagnosis of prostate cancer
10/02/2003US20030185825 Novel immunotoxins and methods of inducing immune tolerance
10/02/2003US20030185824 Administering an inhibitor of the CD2/LFA-3 interaction, in combination with an auxiliary agent, such as UV-B
10/02/2003US20030185823 Arming of activated T cells with BiAbs increases the effective precursor frequency of CTL in the cancer patient.
10/02/2003US20030185822 HLA-A2.1 binding peptides and their uses
10/02/2003US20030185821 Antibodies to interleukin-4 receptors and uses thereof
10/02/2003US20030185820 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof
10/02/2003US20030185819 Treatment of specific and non-specific inflammation, including asthma; useful in diagnosing and localizing sites of inflammation.
10/02/2003US20030185818 Humanized antibody against cd18
10/02/2003US20030185816 Modified immunogenic self-protein and a surfactant capable of acting as a solubiliser, especially modified human TNF alpha and cetylpyridinium chloride
10/02/2003US20030185815 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/02/2003US20030185800 Human interferon-epsilon: a type I interferon
10/02/2003US20030185798 Biocompatible polymers including peptide spacer
10/02/2003US20030185797 Synferon
10/02/2003US20030185792 Mimic or enhance the physiological effects of a morphogenic protein, for example OP-1.
10/02/2003US20030185791 TNF-derived peptides for use in treating oedema
10/02/2003US20030185790 Methods of ex-vivo expansion of hematopoeitic cells using multivariant IL-3 hematopoiesis chimera proteins
10/02/2003US20030185755 Novel ectoparasite saliva proteins and apparatus to collect such proteins
10/02/2003CA2484044A1 Imidazoquinolineamines as adjuvants in hiv dna vaccination
10/02/2003CA2481556A1 Modified plasminogen activator inhibitor type-1 and methods based thereon
10/02/2003CA2480388A1 Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions
10/02/2003CA2480099A1 Erbb3 based methods and compositions for treating neoplasms
10/02/2003CA2480050A1 Tenascin-w compositions and uses thereof
1 ... 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 ... 2916